Heron Therapeutics (HRTX) News Today $1.35 -0.04 (-2.88%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$1.38 +0.02 (+1.85%) As of 08/29/2025 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HRTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Heron Therapeutics Signs New Headquarters LeaseAugust 28 at 5:30 PM | tipranks.comHeron Therapeutics: The View From 30,000 Feet Amid The Zynrelef LaunchAugust 25, 2025 | seekingalpha.comHeron Therapeutics (NASDAQ:HRTX) Rating Increased to Strong Sell at Zacks ResearchAugust 17, 2025 | marketbeat.comHeron Therapeutics adopts tax benefits preservation planAugust 16, 2025 | msn.comHeron Therapeutics, Inc. Adopts Tax Benefits Preservation Plan to Protect NOL Assets and Shareholder ValueAugust 15, 2025 | prnewswire.comXTX Topco Ltd Sells 213,080 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)August 15, 2025 | marketbeat.comInsider Buying: Heron Therapeutics, Inc. (NASDAQ:HRTX) Major Shareholder Acquires 2,387,225 Shares of StockAugust 14, 2025 | marketbeat.comInsider Buying: Heron Therapeutics, Inc. (NASDAQ:HRTX) Director Purchases 1,766,546 Shares of StockAugust 14, 2025 | marketbeat.comInformed Momentum Co LLC Invests $768,000 in Heron Therapeutics, Inc. (NASDAQ:HRTX)August 14, 2025 | marketbeat.comHeron Therapeutics, Inc. (NASDAQ:HRTX) Director Buys $2,649,819.00 in StockAugust 13, 2025 | insidertrades.comHeron Therapeutics Signs Agreement with PatheonAugust 12, 2025 | msn.comHeron Therapeutics Announces Strategic Financial InitiativesAugust 12, 2025 | theglobeandmail.comRubric capital buys Heron Therapeutics (HRTX) shares worth $3.5mAugust 12, 2025 | investing.comHeron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | msn.comHeron Therapeutics (NASDAQ:HRTX) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPSAugust 11, 2025 | marketbeat.comHeron Therapeutics (NASDAQ:HRTX) Price Target Cut to $3.00 by Analysts at Needham & Company LLCAugust 10, 2025 | marketbeat.comWall Street Zen Downgrades Heron Therapeutics (NASDAQ:HRTX) to HoldAugust 10, 2025 | marketbeat.comHeron Therapeutics, Inc.: Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity ProfileAugust 8, 2025 | finanznachrichten.deHeron Therapeutics, Inc. (HRTX) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comHeron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity ProfileAugust 8, 2025 | prnewswire.comHeron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial ProgressAugust 8, 2025 | prnewswire.comHeron Therapeutics Reschedules Second Quarter 2025 Earnings Release and Conference Call to Friday, August 8, 2025August 8, 2025 | prnewswire.comJefferies Financial Group Inc. Makes New Investment in Heron Therapeutics, Inc. (NASDAQ:HRTX)August 6, 2025 | marketbeat.comTD Asset Management Inc Invests $868,000 in Heron Therapeutics, Inc. (NASDAQ:HRTX)August 5, 2025 | marketbeat.comHeron Therapeutics (HRTX) to Release Earnings on TuesdayJuly 30, 2025 | marketbeat.comMonaco Asset Management SAM Lowers Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX)July 30, 2025 | marketbeat.comHeron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025July 28, 2025 | prnewswire.comHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Acquired by New York State Common Retirement FundJuly 23, 2025 | marketbeat.com2,778,200 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Purchased by AIGH Capital Management LLCJuly 22, 2025 | marketbeat.comHeron Therapeutics: Middling Performance From Approved Therapies With No PipelineJuly 22, 2025 | seekingalpha.comHRTX Heron Therapeutics, Inc. - Seeking AlphaJuly 10, 2025 | seekingalpha.comHeron Therapeutics (NASDAQ:HRTX) Stock Crosses Above 200-Day Moving Average - Time to Sell?July 9, 2025 | marketbeat.comPalisade Capital Management LP Purchases 1,360,542 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)July 3, 2025 | marketbeat.comWith 60% institutional ownership, Heron Therapeutics, Inc. (NASDAQ:HRTX) is a favorite amongst the big gunsJuly 1, 2025 | finance.yahoo.comHeron Therapeutics (NASDAQ:HRTX) Stock Crosses Above Two Hundred Day Moving Average - What's Next?July 1, 2025 | marketbeat.comCongress Park Capital LLC Has $4.48 Million Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX)June 20, 2025 | marketbeat.comHeron Therapeutics (NASDAQ:HRTX) Stock Price Crosses Above 200 Day Moving Average - Here's WhyJune 19, 2025 | marketbeat.comHC Wainwright & Co. Initiates Coverage of Heron Therapeutics (HRTX) with Buy RecommendationJune 11, 2025 | msn.comQ2 Earnings Forecast for HRTX Issued By HC WainwrightJune 11, 2025 | marketbeat.comHeron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Millennium Management LLCJune 11, 2025 | marketbeat.comHeron Therapeutics (NASDAQ:HRTX) Now Covered by Analysts at HC WainwrightJune 9, 2025 | marketbeat.comJane Street Group LLC Sells 284,299 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)June 9, 2025 | marketbeat.comHeron Therapeutics (NASDAQ:HRTX) Upgraded by Wall Street Zen to Buy RatingJune 6, 2025 | marketbeat.comNuveen Asset Management LLC Reduces Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX)June 6, 2025 | marketbeat.comTwo Sigma Investments LP Sells 411,906 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)June 4, 2025 | marketbeat.comHeron Therapeutics (NASDAQ:HRTX) Stock Rating Lowered by Wall Street ZenMay 24, 2025 | marketbeat.comPoint72 Asset Management L.P. Purchases Shares of 3,075,809 Heron Therapeutics, Inc. (NASDAQ:HRTX)May 22, 2025 | marketbeat.comStonepine Capital Management LLC Invests $1.07 Million in Heron Therapeutics, Inc. (NASDAQ:HRTX)May 20, 2025 | marketbeat.comTang Capital Management LLC Boosts Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX)May 20, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 660,971 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)May 19, 2025 | marketbeat.com Get Heron Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HRTX Media Mentions By Week HRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRTX News Sentiment▼1.111.05▲Average Medical News Sentiment HRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRTX Articles This Week▼33▲HRTX Articles Average Week Get the Latest News and Ratings for HRTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Heron Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Phathom Pharmaceuticals News Today Anavex Life Sciences News Today Akebia Therapeutics News Today Valneva News Today Niagen Bioscience News Today Sana Biotechnology News Today Taysha Gene Therapies News Today Gyre Therapeutics News Today ArriVent BioPharma News Today BGM Group News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRTX) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
